Bio Elpida, facilities dedicated to the development of bio-pharmaceuticals
120 m² of Feasibility Laboratories

Bio Elpida provides two types of feasibility laboratories:
  • 60 m² dedicated to the research and development for prokaryote cell programmes
  • 60 m² dedicated to the research and development for eukaryotic cell programmes

Quality insurance and GMP rules are applied as early as feasibility phases

A distinctive feature of Bio Elpida is to apply quality insurance and GMP as early as feasibility phases. This approach ensures optimal transfer of processes to GMP manufacturing and pharmaceutical zones as well as scale-up.

Bio Elpida

Founded in 2009, Bio Elpida is a Biotechnology Contract Development and Manufacturing Company specialised in the development and manufacturing of innovative cell therapies.

The expertise of the company covers 3 areas:
In these areas, Bio Elpida offers services that include:
Bio Elpida is the first French laboratory certified by the French Health Authorities (MSNA) as a Pharmaceutical Company and authorised to manufacture Active Pharmaceutical Ingredients for experimental biological pharmaceuticals.
Expertise
Services
R&D and Feasibility
Pharmaceutical Development
Single-Use Approach
Optimisation & Scale up
Analytical Method
Manufacturing and Control
Testing
Aseptic Fill & Finish
Support
Formulation
Regulation IMPD
Drug Analytical Development
Bulk Purification


Facilities
R&D Facilities
Feasibility Facilities
API Facilities
ATMP Facilities

Team


Company

News

Contact
Bio Elpida - 97 allée Alexandre Borodine - Bâtiment 5 Cèdre 1 - 69800 Saint Priest - FRANCE - Phone: +33 (0)4 78 47 02 70 - Mail: infos@bio-elpida.com
© Bio Elpida. All Rights Reserved - Legal information - Web site by: Estium-Concept
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  •  
  •  
  •